ID: ALA4291398

Max Phase: Preclinical

Molecular Formula: C10H6N6S

Molecular Weight: 242.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Sc1nnc2c3nncn3c3ccccc3n12

Standard InChI:  InChI=1S/C10H6N6S/c17-10-14-13-9-8-12-11-5-15(8)6-3-1-2-4-7(6)16(9)10/h1-5H,(H,14,17)

Standard InChI Key:  XDTQJDBSBWYUHG-UHFFFAOYSA-N

Associated Targets(Human)

HEp-2 3859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Caco-2 12174 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA topoisomerase II alpha 6317 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Calf thymus DNA 4845 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 242.27Molecular Weight (Monoisotopic): 242.0375AlogP: 1.21#Rotatable Bonds: 0
Polar Surface Area: 60.38Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.63CX Basic pKa: 1.02CX LogP: -0.55CX LogD: -0.74
Aromatic Rings: 4Heavy Atoms: 17QED Weighted: 0.47Np Likeness Score: -1.94

References

1. Ibrahim MK, Taghour MS, Metwaly AM, Belal A, Mehany ABM, Elhendawy MA, Radwan MM, Yassin AM, El-Deeb NM, Hafez EE, ElSohly MA, Eissa IH..  (2018)  Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors.,  155  [PMID:29885574] [10.1016/j.ejmech.2018.06.004]

Source